Human assembloid of human blood vessel organoids with pancreatic islets improves insulin secretion over time ex vivo
- PMID: 41045457
- DOI: 10.1016/j.celrep.2025.116378
Human assembloid of human blood vessel organoids with pancreatic islets improves insulin secretion over time ex vivo
Abstract
Pancreatic islet transplantation is a promising treatment strategy for type 1 diabetes patients; however, there are still major challenges to overcome, including vascularization. Despite a substantial need to understand the islet graft decline observed in patients 5-10 years post transplantation, clinical translation remains challenging, probably because of species-specific features and the lack of in vitro vascularized models. Here, we report results of a human assembloid composed of self-organizing 3D blood vessel organoids (BVOs) with human pancreatic islets. We demonstrate that co-culture of islets and BVOs ex vivo leads to an auto-organized assembloid (by light-sheet fluorescence microscopy) and improves insulin secretion over time (functionality assays) on 5 independent human islet donors (from 3 different hospital facilities). Taken together, this study could accelerate our understanding of type 1 diabetes and facilitate therapeutic development for type 1 diabetes patients.
Keywords: CP: Stem cell research; assembloid; blood vessel organoid; islet transplantation; pancreas; type 1 diabetes.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests J.P. is one of the authors of the patent application US20200199541A1 relating to blood vessel organoid generation. Furthermore, J.P. is a founder, shareholder, and chairman of the scientific advisory board of Angios Biotech, a company establishing BVOs for drug testing and vascular transplants.
LinkOut - more resources
Full Text Sources
Miscellaneous
